These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11042183)

  • 1. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent.
    Hooks SB; Santos WL; Im DS; Heise CE; Macdonald TL; Lynch KR
    J Biol Chem; 2001 Feb; 276(7):4611-21. PubMed ID: 11042183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors.
    Xu J; Love LM; Singh I; Zhang QX; Dewald J; Wang DA; Fischer DJ; Tigyi G; Berthiaume LG; Waggoner DW; Brindley DN
    J Biol Chem; 2000 Sep; 275(36):27520-30. PubMed ID: 10849424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.
    Ishii I; Contos JJ; Fukushima N; Chun J
    Mol Pharmacol; 2000 Nov; 58(5):895-902. PubMed ID: 11040035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid.
    Erickson JR; Wu JJ; Goddard JG; Tigyi G; Kawanishi K; Tomei LD; Kiefer MC
    J Biol Chem; 1998 Jan; 273(3):1506-10. PubMed ID: 9430689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
    Hernández M; Barrero MJ; Crespo MS; Nieto ML
    J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
    Goetzl EJ; Kong Y; Mei B
    J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator.
    Takuwa Y; Okamoto H; Takuwa N; Gonda K; Sugimoto N; Sakurada S
    Mol Cell Endocrinol; 2001 May; 177(1-2):3-11. PubMed ID: 11377814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K; Ishii S; Shimizu T
    J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.
    Fukushima N; Kimura Y; Chun J
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6151-6. PubMed ID: 9600933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
    Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
    Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor.
    Goetzl EJ; Kong Y; Kenney JS
    Proc Assoc Am Physicians; 1999; 111(3):259-69. PubMed ID: 10354366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential stimulation of signaling pathways initiated by Edg-2 in response to lysophosphatidic acid or sphingosine-1-phosphate.
    Peyruchaud O; Mosher DF
    Cell Mol Life Sci; 2000 Jul; 57(7):1109-16. PubMed ID: 10961347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
    Im DS; Heise CE; Harding MA; George SR; O'Dowd BF; Theodorescu D; Lynch KR
    Mol Pharmacol; 2000 Apr; 57(4):753-9. PubMed ID: 10727522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDG receptors and hepatic pathophysiology of LPA and S1P: EDG-ology of liver injury.
    Svetlov SI; Sautin YY; Crawford JM
    Biochim Biophys Acta; 2002 May; 1582(1-3):251-6. PubMed ID: 12069835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid-induced Ca2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptors.
    Young KW; Bootman MD; Channing DR; Lipp P; Maycox PR; Meakin J; Challiss RA; Nahorski SR
    J Biol Chem; 2000 Dec; 275(49):38532-9. PubMed ID: 10954727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.